Adaptive Biotechnologies Corp (ADPT) — Capital Reinvestment Ratio

Latest as of March 2019: 0.01x

Adaptive Biotechnologies Corp (ADPT) has a Capital Reinvestment Ratio of 0.01x as of March 2019, meaning it reinvests 0% of its operating cash flow ($278.30 Million) in capital expenditures ($3.83 Million). Check Adaptive Biotechnologies Corp tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$278.30 Million
USD

Capital Expenditures

$3.83 Million
USD

Data as of

Mar 2019
Most recent filing

Adaptive Biotechnologies Corp Capital Reinvestment Ratio (2019–2019)

This chart tracks Adaptive Biotechnologies Corp's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ADPT cash flow metrics.

Annual Capital Reinvestment Ratio for Adaptive Biotechnologies Corp (2019–2019)

Year-by-year Capital Reinvestment Ratio for Adaptive Biotechnologies Corp from 2019 to 2019. See Adaptive Biotechnologies Corp free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.05x $205.40 Million $11.20 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow